Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
4015 results
Interventional
Phase3
1000
NNS0487-0111
Semaglutide
Placebo (matched to NNC0487-0111)
Placebo (matched to semaglutide)
Novo Nordisk A/S
Source: clinicaltrials.gov
Observational
Not Applicable
250
Completion of the IDTN Questionnaire
University College, London
20
College Park ICON
Conventional NMPK
VA Office of Research and Development
2000
Coronary computed tomographic angiography with CT - derived fractional flow reserve
Qilu Hospital of Shandong University
360
Prenatal maternal psychosocial and biological assessment protocol
Columbia University
1824
AI
Chinese University of Hong Kong
Phase2
Darolutamide
ADT
Bayer
48
Radiofrequency diathermy (RFD)
Sham radiofrequency diathermy ( sham RFD)
University of Valencia
Phase1
60
Rituximab
Fludarabine
TGFBR2 KO CAR27/IL-15 NK cells
Cyclophosphamide
M.D. Anderson Cancer Center
9
LUT017,Topical BRAF inhibitor
Antoni Ribas